CZ20013404A3 - Farmaceutický přípravek obsahující tolperison k orálnímu podávání - Google Patents
Farmaceutický přípravek obsahující tolperison k orálnímu podávání Download PDFInfo
- Publication number
- CZ20013404A3 CZ20013404A3 CZ20013404A CZ20013404A CZ20013404A3 CZ 20013404 A3 CZ20013404 A3 CZ 20013404A3 CZ 20013404 A CZ20013404 A CZ 20013404A CZ 20013404 A CZ20013404 A CZ 20013404A CZ 20013404 A3 CZ20013404 A3 CZ 20013404A3
- Authority
- CZ
- Czechia
- Prior art keywords
- tolperisone
- preparation
- composition according
- racemate
- formulated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0059499A AT409083B (de) | 1999-04-01 | 1999-04-01 | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ20013404A3 true CZ20013404A3 (cs) | 2002-02-13 |
Family
ID=3494723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20013404A CZ20013404A3 (cs) | 1999-04-01 | 1999-11-16 | Farmaceutický přípravek obsahující tolperison k orálnímu podávání |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6500455B1 (https=) |
| EP (1) | EP1165081B1 (https=) |
| JP (1) | JP2002541107A (https=) |
| AT (1) | AT409083B (https=) |
| AU (1) | AU1136400A (https=) |
| CA (1) | CA2366841C (https=) |
| CZ (1) | CZ20013404A3 (https=) |
| DE (1) | DE59912101D1 (https=) |
| EE (1) | EE04833B1 (https=) |
| ES (1) | ES2168241T3 (https=) |
| HR (1) | HRPK20010706B1 (https=) |
| HU (1) | HUP0200669A3 (https=) |
| IL (2) | IL145559A0 (https=) |
| NO (1) | NO20014738L (https=) |
| NZ (1) | NZ514129A (https=) |
| PL (1) | PL197545B1 (https=) |
| PT (1) | PT1165081E (https=) |
| RU (1) | RU2223098C2 (https=) |
| SK (1) | SK13642001A3 (https=) |
| TR (1) | TR200102811T2 (https=) |
| UA (1) | UA71613C2 (https=) |
| WO (1) | WO2000059508A1 (https=) |
| YU (1) | YU67501A (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0300929A3 (en) * | 2003-04-09 | 2005-06-28 | Richter Gedeon Vegyeszet | Analgetic and/or muscle relaxant pharmaceutical composition |
| DE10341923A1 (de) * | 2003-09-11 | 2005-04-07 | Heinl, Alexander, Dr.med. | Verwendung von Tolperison |
| US20050089559A1 (en) * | 2003-10-23 | 2005-04-28 | Istvan Szelenyi | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| DE10359335A1 (de) * | 2003-10-23 | 2005-05-25 | Viatris Gmbh & Co. Kg | Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen |
| AT500144A1 (de) * | 2004-03-05 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung |
| MX2008013437A (es) * | 2006-04-20 | 2009-03-06 | Sanochemia Pharmazeutika Ag | Metodo para administrar tolperisona. |
| US7960436B2 (en) | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
| US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
| BRPI0716715B1 (pt) | 2006-08-23 | 2021-07-06 | Xenon Pharmaceuticals, Inc | Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potássio, seus usos, produto, composição, comprimido e cápsula |
| US8722929B2 (en) | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
| CA2670966A1 (en) * | 2006-11-28 | 2008-06-05 | Valeant Pharmaceuticals International | 1,4 diamino bicyclic retigabine analogues as potassium channel modulators |
| AT505225A1 (de) | 2007-04-26 | 2008-11-15 | Sanochemia Pharmazeutika Ag | 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen |
| US8367684B2 (en) | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
| HUP0700485A3 (en) * | 2007-07-23 | 2010-01-28 | Richter Gedeon Nyrt | Pharmaceutical composition with controlled release containing tolperisone |
| US8563566B2 (en) | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
| US7786146B2 (en) | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| US8865732B2 (en) | 2008-03-21 | 2014-10-21 | Novartis Ag | Heterocyclic compounds and uses thereof |
| US20100249423A1 (en) * | 2009-03-09 | 2010-09-30 | Sanochemia Pharmazeutika Ag | Tolperisone controlled release tablet |
| EA201171109A1 (ru) | 2009-03-09 | 2012-03-30 | Динеш Шантилал Пател | Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия |
| TWI886158B (zh) | 2019-10-10 | 2025-06-11 | 加拿大商再諾製藥公司 | 選擇性鉀通道調節劑之固態晶型 |
| WO2021092439A1 (en) | 2019-11-08 | 2021-05-14 | Xenon Pharmaceuticals Inc. | Methods of treating depressive disorders |
| IL304920A (en) | 2021-02-09 | 2023-10-01 | Xenon Pharmaceuticals Inc | A voltage-gated potassium channel opener for use in the treatment of anhedonia |
| USD1109826S1 (en) | 2024-02-16 | 2026-01-20 | Coulter Ventures, Llc. | Weightlifting assembly |
| WO2026074301A1 (en) | 2024-10-02 | 2026-04-09 | Meditop Gyógyszeripari Kft | Sustained release oral medicinal product containing tolperisone hydrochloride, its production and use |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5154918A (en) * | 1974-10-08 | 1976-05-14 | Nippon Kayaku Kk | Jozaino seizoho |
| JPS5191315A (ja) * | 1975-02-06 | 1976-08-10 | Anteinaensantoruperizonshirotsupunoseizoho | |
| JPS5340779A (en) * | 1976-09-21 | 1978-04-13 | Nippon Kayaku Co Ltd | Optically active tolpertisone, their preparation and pharmaceuticals containting the same |
| JPS58135806A (ja) * | 1982-02-08 | 1983-08-12 | Nippon Kayaku Co Ltd | 多層コ−チング製剤 |
| JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
| JPH0637389B2 (ja) * | 1986-12-26 | 1994-05-18 | 北陸製薬株式会社 | 頻尿治療剤 |
| JPH0720866B2 (ja) | 1987-05-15 | 1995-03-08 | 三生製薬株式会社 | エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤 |
| IL87710A (en) | 1987-09-18 | 1992-06-21 | Ciba Geigy Ag | Covered floating retard form for controlled release in gastric juice |
| MY115126A (en) * | 1990-04-27 | 2003-04-30 | Seikisui Chemical Co Ltd | Percutaneously absorbable eperisone or tolperisone preparation. |
| US5128145A (en) * | 1990-06-13 | 1992-07-07 | Alza Corporation | Dosage form for Parkinson's disease, spasticity and muscle spasms |
| TW209174B (https=) * | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
| ATE154241T1 (de) * | 1991-10-01 | 1997-06-15 | Takeda Chemical Industries Ltd | Mikropartikeln-zusammenfassung zur verlängerten freigabe und herstellung derselbe |
| US5811547A (en) * | 1992-10-14 | 1998-09-22 | Nippon Shinyaju Co., Ltd. | Method for inducing crystalline state transition in medicinal substance |
| GB9319606D0 (en) * | 1993-09-22 | 1993-11-10 | Glaxo Group Ltd | Chemical compounds |
-
1999
- 1999-04-01 AT AT0059499A patent/AT409083B/de not_active IP Right Cessation
- 1999-11-16 RU RU2001129368/15A patent/RU2223098C2/ru not_active IP Right Cessation
- 1999-11-16 PT PT99973809T patent/PT1165081E/pt unknown
- 1999-11-16 IL IL14555999A patent/IL145559A0/xx unknown
- 1999-11-16 CA CA002366841A patent/CA2366841C/en not_active Expired - Fee Related
- 1999-11-16 HU HU0200669A patent/HUP0200669A3/hu unknown
- 1999-11-16 JP JP2000609071A patent/JP2002541107A/ja not_active Withdrawn
- 1999-11-16 ES ES99973809T patent/ES2168241T3/es not_active Expired - Lifetime
- 1999-11-16 YU YU67501A patent/YU67501A/sh unknown
- 1999-11-16 US US09/937,710 patent/US6500455B1/en not_active Expired - Lifetime
- 1999-11-16 EP EP99973809A patent/EP1165081B1/de not_active Expired - Lifetime
- 1999-11-16 DE DE59912101T patent/DE59912101D1/de not_active Expired - Fee Related
- 1999-11-16 EE EEP200100503A patent/EE04833B1/xx not_active IP Right Cessation
- 1999-11-16 TR TR2001/02811T patent/TR200102811T2/xx unknown
- 1999-11-16 SK SK1364-2001A patent/SK13642001A3/sk unknown
- 1999-11-16 NZ NZ514129A patent/NZ514129A/xx unknown
- 1999-11-16 WO PCT/AT1999/000276 patent/WO2000059508A1/de not_active Ceased
- 1999-11-16 PL PL351377A patent/PL197545B1/pl not_active IP Right Cessation
- 1999-11-16 CZ CZ20013404A patent/CZ20013404A3/cs unknown
- 1999-11-16 UA UA2001117476A patent/UA71613C2/uk unknown
- 1999-11-16 HR HR20010706 patent/HRPK20010706B1/xx not_active IP Right Cessation
- 1999-11-18 AU AU11364/00A patent/AU1136400A/en not_active Abandoned
-
2001
- 2001-09-23 IL IL145559A patent/IL145559A/en not_active IP Right Cessation
- 2001-09-28 NO NO20014738A patent/NO20014738L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000059508A1 (de) | 2000-10-12 |
| AU1136400A (en) | 2000-10-23 |
| HUP0200669A3 (en) | 2002-11-28 |
| IL145559A0 (en) | 2002-06-30 |
| EE200100503A (et) | 2003-02-17 |
| ES2168241T1 (es) | 2002-06-16 |
| UA71613C2 (uk) | 2004-12-15 |
| PT1165081E (pt) | 2005-08-31 |
| HRPK20010706B1 (en) | 2004-12-31 |
| NO20014738D0 (no) | 2001-09-28 |
| RU2223098C2 (ru) | 2004-02-10 |
| PL197545B1 (pl) | 2008-04-30 |
| CA2366841A1 (en) | 2000-10-12 |
| SK13642001A3 (sk) | 2002-03-05 |
| EP1165081B1 (de) | 2005-05-25 |
| EE04833B1 (et) | 2007-06-15 |
| NO20014738L (no) | 2001-10-23 |
| JP2002541107A (ja) | 2002-12-03 |
| AT409083B (de) | 2002-05-27 |
| HRP20010706A2 (en) | 2003-02-28 |
| IL145559A (en) | 2008-12-29 |
| ATA59499A (de) | 2001-10-15 |
| YU67501A (sh) | 2004-07-15 |
| TR200102811T2 (tr) | 2002-05-21 |
| CA2366841C (en) | 2008-10-07 |
| DE59912101D1 (de) | 2005-06-30 |
| US6500455B1 (en) | 2002-12-31 |
| EP1165081A1 (de) | 2002-01-02 |
| HUP0200669A2 (hu) | 2002-07-29 |
| PL351377A1 (en) | 2003-04-07 |
| ES2168241T3 (es) | 2005-11-01 |
| NZ514129A (en) | 2003-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ20013404A3 (cs) | Farmaceutický přípravek obsahující tolperison k orálnímu podávání | |
| AU2006298895B2 (en) | Pharmaceutical preparation containing meloxicam | |
| FI82187B (fi) | Foerfarande foer framstaellning av lagerstabila snabbsoenderfallande farmaceutiska aktivaemnespresstycken. | |
| AU2002318155B2 (en) | Solid pharmaceutical formulations comprising modafinil | |
| EP1725218A1 (en) | Pharmaceutical composition comprising pimobendan | |
| EA014707B1 (ru) | Новая форма введения рацекадотрила | |
| KR101125361B1 (ko) | 모다피닐의 신규한 제약 제제 | |
| WO2009074995A1 (en) | Taste masked chewable compositions of sildenafil citrate | |
| KR20010031952A (ko) | 카르베디롤을 위한 신규 경구 투여형 | |
| JP2008536922A (ja) | オランザピンの医薬用経口崩壊錠 | |
| CA1334933C (en) | Pharmaceutical composition and process for its preparation | |
| US20090149543A1 (en) | Solid pharmaceutical compositions comprising lumiracoxib | |
| CZ20001720A3 (cs) | Nová orální dávková forma pro karvedilol |